WITHDRAWN: Novel diagnostic and prognostic value of circulating miR-18a in the plasma of patients with bladder cancer

Rui-Xia Song,Gong-Jian Zhu,Chen-Ming Dong,Zhi-Ping Wang
DOI: https://doi.org/10.1016/j.clinbiochem.2020.12.006
IF: 3.625
2020-12-01
Clinical Biochemistry
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>MiR-18a has been reported in many cancer types, including prostate cancer, gastric cancer, nasopharyngeal carcinoma, esophageal squamous cell carcinoma and breast cancer. Nevertheless, the role of miR-18a remains unclear in bladder cancer.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The expression of miR-18a in bladder cancer tissues was evaluated by qRT-PCR. The diagnostic value of plasma miR-18a was detected by receiver operating characteristic (ROC) analysis. Survival analysis was performed using Kaplan-Meier, and the prognostic significance of miR-18a was analyzed using Cox regression analysis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>MiR-18a was observed to be upregulated in human bladder cancer tissues. Moreover, the expression of plasma miR-18a was found to be closely associated with tumor type, histological grade, TNM stage and tumor size. High expression of miR-18a was found to be capable of predicting unfavorable clinical prognosis in bladder cancer patients. Notably, plasma miR-18a expression was shown to exhibit fundamental diagnostic significance in discriminating bladder cancer patients from healthy individuals, and in differentiating muscle invasive bladder cancer (MIBC) from non-muscle invasive bladder cancer (NMIBC).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>This study demonstrated that miR-18a is a potential diagnostic biomarker associated with the prognosis of bladder cancer patients. Hence, miR-18a may be a useful biomarker for the screening of bladder cancer.</p>
medical laboratory technology
What problem does this paper attempt to address?